Open AccessResults of a three-day outpatient trial of plasmocid and osarsol for malaria
Author(s) -
E. G. Epshtein
Publication year - 1935
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj51049
Subject(s) - malaria , peripheral blood , medicine , pediatrics , immunology
Over the past three years, many observations on the use of plasmacide have already accumulated. Treatment of three-day malaria with plasmacid relieves febrile attacks in 93-94% of cases. The disappearance of plasmodium from peripheral blood occurs in 76-86%. In the course of treatment with plasmacid, relapses were recorded in 20-22%, occurring more often on the 2-3rd cycle of plasmacid application.